Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy

被引:90
作者
Schwickert, HC
Stiskal, M
Roberts, TPL
vanDijke, CF
Mann, J
Muhler, A
Shames, DM
Demsar, F
Disston, A
Brasch, RC
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT RADIOL,CONTRAST MEDIA LAB,SAN FRANCISCO,CA 94143
[2] SCHERING AG,INST CONTRAST MEDIA RES,W-1000 BERLIN,GERMANY
关键词
breast; neoplasms; therapy; chemotherapy; gadolinium; magnetic resonance (MR); contrast enhancement; blood supply; MR;
D O I
10.1148/radiology.198.3.8628889
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To assess the effect of x rays on tumor capillary permeability with macromolecular contrast medium (MMCM)-enhanced magnetic resonance (MR) imaging. MATERIALS AND METHODS: One of paired R3230 mammary adenocarcinomas implanted in the flanks of 48 Fischer rats was treated with a single 5- or 15-Gy dose of x rays. After 1 or 3 days, MR imaging in 30 rats was performed unenhanced and enhanced with albumin-(gadolinium diethylenetriaminepent aacetic acid)(30) (0.02 mmol gadolinium per kilogram body weight). Signal intensity enhancement was analyzed to estimate fractional blood volume and permeability-surface area product (PS). In 18 irradiated rats, 2.5 mg/kg cisplatin was injected intravenously, and fractional tumor platinum concentrations were measured spectrometrically. RESULTS: MR imaging showed highest capillary permeability 1 day after 15 Gy (PS 110% above control [P <.001]); PS was elevated 57% 1 day after 5 Gy and 63% 3 days after 15 Gy (P <.05). The largest mean tumor platinum fraction occurred 1 day after 15 Gy: 48% versus 20% (control) (P <.05). CONCLUSION: Transient irradiation-induced increase in tumor capillary permeability to cisplatin can be quantified with MMCM-enhanced MR imaging.
引用
收藏
页码:893 / 898
页数:6
相关论文
共 72 条
[1]  
ACKERMAN NB, 1978, SURG GYNECOL OBSTET, V146, P884
[2]   DYNAMIC CONTRAST-ENHANCED MR-IMAGING OF THE UPPER ABDOMEN - ENHANCEMENT PROPERTIES OF GADOBUTROL, GADOLINIUM-DTPA-POLYLYSINE, AND GADOLINIUM-DTPA-CASCADE-POLYMER [J].
ADAM, G ;
NEUERBURG, J ;
SPUNTRUP, E ;
MUHLER, A ;
SCHERER, K ;
GUNTHER, RW .
MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (05) :622-628
[3]   A PRELIMINARY ASSESSMENT OF FACTORS ASSOCIATED WITH RECURRENT DISEASE IN A SURGICAL ADJUVANT CLINICAL-TRIAL FOR PATIENTS WITH BREAST-CANCER WITH SPECIAL EMPHASIS ON THE AGGRESSIVENESS OF THERAPY [J].
AHMANN, DL ;
OFALLON, JR ;
SCANLON, PW ;
PAYNE, WS ;
BISEL, HF ;
EDMONSON, JH ;
FRYTAK, S ;
HAHN, RG ;
INGLE, JN ;
RUBIN, J ;
CREAGAN, ET .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04) :371-381
[4]  
AICHER KP, 1990, CANCER RES, V50, P7376
[5]  
ANDRASI E, 1990, BIOL TRACE ELEMENT R, P691
[6]  
BOGDEN AE, 1976, BREAST CANCER TRENDS, P95
[7]  
BOGDEN AE, 1989, ADV RES TREATMENT EX, V2, P283
[8]  
BRASCH RC, 1992, RADIOLOGY, V183, P1
[9]  
BUZDAR AU, 1990, CANCER, V65, P394, DOI 10.1002/1097-0142(19900201)65:3<394::AID-CNCR2820650303>3.0.CO
[10]  
2-2